Loss of HMCES is synthetic lethal with APOBEC activity in cancer cells
J. Biayna, I. Garcia-Cao, M. M. Alvarez, M. Salvadores, J. Espinosa-Carrasco, M. McCullough, F. Supek, T. H. Stracker
The paper identifies HMCES as a synthetic lethal partner of APOBEC3A in cancer cells, showing its role in protecting against DNA damage and its potential as a therapeutic target.
bioRxiv · Feb 5, 2021 · PreprintCancer Biology